Patents by Inventor Kan Agarwal

Kan Agarwal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gastrokines and derived peptides including inhibitors
    Patent number: 7557083
    Abstract: A novel group of gastrokines called Gastric Antrum Mucosal Protein is characterized. A member of the group is designated AMP-18. AMP-18 genomic DNA, cDNA and the AMP-18 protein are sequenced for human, mouse and pig. The AMP-18 protein and active peptides derived from it are cellular growth factors. Surprisingly, peptides capable of inhibiting the effects of the complete protein, are also derived from the AMP-18 protein. Control of mammalian gastro-intestinal tissues growth and repair is facilitated by the use of the proteins, making the proteins candidates for therapies.
    Type: Grant
    Filed: March 29, 2002
    Date of Patent: July 7, 2009
    Assignee: The University of Chicago
    Inventors: Terence E. Martin, F. Gary Toback, Thomas C. Powell, Miriana Choudhary, legal representative, Kan Agarwal
  • Gastrokines and derived peptides including inhibitors
    Publication number: 20050065328
    Abstract: A novel group of gastrokines called Gastric Antrum Mucosal Protein is characterized. A member of the group is designated AMP-18. AMP-18 genomic DNA, cDNA and the AMP-18 protein are sequenced for human, mouse and pig. The AMP-18 protein and active peptides derived from it are cellular growth factors. Surprisingly, peptides capable of inhibiting the effects of the complete protein, are also derived from the AMP-18 protein. Control of mammalian gastro-intestinal tissues growth and repair is facilitated by the use of the proteins, making the proteins candidates for therapies.
    Type: Application
    Filed: March 29, 2002
    Publication date: March 24, 2005
    Inventors: Terence Martin, F. Toback, Thomas Powell, Kan Agarwal
  • Gastrokines and derived peptides including inhibitors
    Patent number: 6734289
    Abstract: A novel group of gastrokines called Gastric Antrum Mucosal Protein is characterized. A member of the group is designated AMP-18. AMP-18 genomic DNA, cDNA and the AMP-18 protein are sequenced for human, mouse and pig. The AMP-18 protein and active peptides derived from it are cellular growth factors. Surprisingly, peptides capable of inhibiting the effects of the complete protein, are also derived from the AMP-18 protein. Control of mammalian gastro-intestinal tissues growth and repair is facilitated by the use of the proteins, making the proteins candidates for therapies.
    Type: Grant
    Filed: March 29, 2001
    Date of Patent: May 11, 2004
    Assignee: The University of Chicago
    Inventors: Terence Martin, F. Gary Toback, C. Thomas Powell, Kan Agarwal
  • Gastrokines and derived peptides including inhibitors
    Publication number: 20030017548
    Abstract: A novel group of gastrokines called Gastric Antrum Mucosal Protein is characterized. A member of the group is designated AMP-18. AMP-18 genomic DNA, cDNA and the AMP-18 protein are sequenced for human, mouse and pig. The AMP-18 protein and active peptides derived from it are cellular growth factors. Surprisingly, peptides capable of inhibiting the effects of the complete protein, are also derived from the AMP-18 protein. Control of mammalian gastro-intestinal tissues growth and repair is facilitated by the use of the proteins, making the proteins candidates for therapies.
    Type: Application
    Filed: March 29, 2001
    Publication date: January 23, 2003
    Inventors: Terence Martin, F. Gary Toback, C. Thomas Powell, Kan Agarwal